Effects of radial extracorporeal shockwave therapy versus high intensity laser therapy in individuals with plantar fasciitis: A randomised clinical trial

Thammajaree, Chutiporn; Theapthong, Montartip; Palee, Phongsathon; Pakpakorn, Phrattaya; Sitti, Tippawan; Sakulsriprasert, Prasert; Bunprajun, Tipwadee; Thong-On, Suthasinee

doi:10.1007/s10103-023-03791-5

Cited by 4 publications

(1 citation statement)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To substantiate the effect of ESWT on pain reduction in patients with PF, previous research findings have demonstrated that ESWT accelerates vascular regeneration by promoting the release of growth factors and facilitating the mobilization of stem cells [ 118 – 120 ]. The results of previous studies in this area also support this finding, indicating a favorable and sustained effect of pain reduction with ESWT in patients with PF [ 118 – 122 ]. In the combination of studies and pooled estimate of the SMD regarding the effect of ESWT on mean pain in patients with PF, the percentage of heterogeneity was 77.36%, which is high but acceptable.…”

Section: Discussionmentioning

confidence: 99%

The effect of extracorporeal shock-wave therapy on pain in patients with various tendinopathies: a systematic review and meta-analysis of randomized control trials

Majidi,

Khateri,

Nikbakht

et al. 2024

BMC Sports Sci Med Rehabil

View full text Add to dashboard Cite

Objectives Tendinopathy is a common condition that affects the body’s tendon structures, causing discomfort, restricted movement, and reduced functionality. In this study, we looked at how extracorporeal shock wave therapy (ESWT) affected pain levels in individuals with various forms of tendinopathy around the world. Design This study is a comprehensive review and meta-analysis of previously published randomized controlled trials. To gather relevant data, the researchers performed keyword searches in international databases, including PubMed (Medline), Scopus, Web of Sciences, Cochrane Central Register of Controlled Trials (CENTRAL), Research Registers of ongoing trials (ClinicalTrials.gov), as well as Embase. The search was conducted up until March 2023. The quality of the selected articles was assessed using the Cochrane risk-of-bias method for randomized trials (RoB2). Results Based on the results of the meta-analysis, which included 45 clinical studies, the use of ESWT was found to have a significant impact on reducing pain in various conditions. The standardized mean difference (SMD) in patients with plantar fasciitis (PF) was reduced by 1.63 (SMD: -1.63, 95% CI: -3.04, -0.21; I2: 77.36%; P heterogeneity: 0.0001). For lateral epicondylitis (LE), the SMD was 0.63 (SMD: -0.63, 95% CI: -1.11, -0.16; I2: 67.50%; P heterogeneity: 0.003). In the case of chronic Achilles tendinopathy, the SMD was 1.38 (SMD: -1.38, 95% CI: -1.66, -1.10; I2: 96.44%; P heterogeneity: 0.0001). Additionally, in individuals with rotator cuff tendinopathy, the SMD for pain reduction was 2.37 units (SMD: -2.37, 95% CI: -3.58, -1.15; I2: 98.46%; P heterogeneity: 0.0001). Conclusion This study suggests that ESWT can be a highly effective therapy option for relieving pain in people with tendinopathy. Nonetheless, it is encouraged to make additional recommendations based on high-quality clinical research and more accurate information in order to define the optimal therapeutic options for each type of tendinopathy.

show abstract

Section: Discussionmentioning

confidence: 99%